vs
Side-by-side financial comparison of Relay Therapeutics, Inc. (RLAY) and TECHPRECISION CORP (TPCS). Click either name above to swap in a different company.
TECHPRECISION CORP is the larger business by last-quarter revenue ($7.1M vs $7.0M, roughly 1.0× Relay Therapeutics, Inc.). TECHPRECISION CORP produced more free cash flow last quarter ($-827.0K vs $-235.9M).
Relay Therapeutics is a clinical-stage biotechnology company focused on developing precision oncology therapies. It leverages advanced computational modeling of protein dynamics, paired with cutting-edge experimental biology, to design targeted medicines for previously intractable cancer types, serving global oncology care markets and patient populations.
TechPrecision Corp is a manufacturer of custom high-precision metal fabricated components and integrated systems, serving aerospace, defense, medical technology, renewable energy, and industrial end markets primarily across North America and Europe. It specializes in producing tight-tolerance, mission-critical parts that adhere to rigorous industry quality requirements.
RLAY vs TPCS — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $7.0M | $7.1M |
| Net Profit | — | $-1.5M |
| Gross Margin | — | 5.4% |
| Operating Margin | — | -19.1% |
| Net Margin | — | -20.8% |
| Revenue YoY | — | -6.9% |
| Net Profit YoY | — | -84.4% |
| EPS (diluted) | — | $-0.15 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $7.0M | $7.1M | ||
| Q3 25 | $0 | $9.1M | ||
| Q2 25 | — | $7.4M | ||
| Q1 25 | $7.7M | $9.5M | ||
| Q4 24 | $0 | $7.6M | ||
| Q3 24 | $0 | $8.9M | ||
| Q2 24 | $0 | $8.0M | ||
| Q1 24 | $10.0M | $8.6M |
| Q4 25 | — | $-1.5M | ||
| Q3 25 | $-74.1M | $825.0K | ||
| Q2 25 | — | $-597.0K | ||
| Q1 25 | $-77.1M | $112.0K | ||
| Q4 24 | — | $-799.0K | ||
| Q3 24 | $-88.1M | $-601.0K | ||
| Q2 24 | $-92.2M | $-1.5M | ||
| Q1 24 | $-81.4M | $-5.1M |
| Q4 25 | — | 5.4% | ||
| Q3 25 | — | 27.1% | ||
| Q2 25 | — | 14.0% | ||
| Q1 25 | — | 22.0% | ||
| Q4 24 | — | 13.0% | ||
| Q3 24 | — | 11.3% | ||
| Q2 24 | — | 3.0% | ||
| Q1 24 | — | 14.3% |
| Q4 25 | — | -19.1% | ||
| Q3 25 | — | 10.4% | ||
| Q2 25 | — | -6.3% | ||
| Q1 25 | -1105.2% | 3.9% | ||
| Q4 24 | — | -9.1% | ||
| Q3 24 | — | -5.5% | ||
| Q2 24 | — | -16.8% | ||
| Q1 24 | -903.0% | -28.6% |
| Q4 25 | — | -20.8% | ||
| Q3 25 | — | 9.1% | ||
| Q2 25 | — | -8.1% | ||
| Q1 25 | -1003.6% | 1.2% | ||
| Q4 24 | — | -10.5% | ||
| Q3 24 | — | -6.7% | ||
| Q2 24 | — | -18.3% | ||
| Q1 24 | -813.3% | -59.5% |
| Q4 25 | — | $-0.15 | ||
| Q3 25 | $-0.43 | $0.08 | ||
| Q2 25 | — | $-0.06 | ||
| Q1 25 | $-0.46 | $0.01 | ||
| Q4 24 | — | $-0.08 | ||
| Q3 24 | $-0.63 | $-0.06 | ||
| Q2 24 | $-0.69 | $-0.16 | ||
| Q1 24 | $-0.62 | $-0.59 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $84.0M | $50.0K |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $567.1M | $8.0M |
| Total Assets | $621.3M | $32.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $84.0M | $50.0K | ||
| Q3 25 | $91.6M | $220.0K | ||
| Q2 25 | — | $143.0K | ||
| Q1 25 | $93.5M | $195.0K | ||
| Q4 24 | $124.3M | $165.0K | ||
| Q3 24 | $152.4M | $132.0K | ||
| Q2 24 | $134.1M | $44.8K | ||
| Q1 24 | $152.9M | $138.0K |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $3.0K | ||
| Q4 24 | — | $19.0K | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $567.1M | $8.0M | ||
| Q3 25 | $607.7M | $9.1M | ||
| Q2 25 | — | $8.2M | ||
| Q1 25 | $721.1M | $8.7M | ||
| Q4 24 | $777.8M | $8.1M | ||
| Q3 24 | $838.9M | $8.9M | ||
| Q2 24 | $681.7M | $7.9M | ||
| Q1 24 | $745.8M | $7.8M |
| Q4 25 | $621.3M | $32.8M | ||
| Q3 25 | $670.0M | $33.8M | ||
| Q2 25 | — | $32.1M | ||
| Q1 25 | $799.4M | $33.5M | ||
| Q4 24 | $871.3M | $32.2M | ||
| Q3 24 | $930.1M | $35.0M | ||
| Q2 24 | $772.5M | $35.7M | ||
| Q1 24 | $841.4M | $34.7M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 0.00× | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-235.5M | $183.0K |
| Free Cash FlowOCF − Capex | $-235.9M | $-827.0K |
| FCF MarginFCF / Revenue | -3370.0% | -11.7% |
| Capex IntensityCapex / Revenue | 5.9% | 14.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-622.7M | $-4.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-235.5M | $183.0K | ||
| Q3 25 | $-62.1M | $-1.1M | ||
| Q2 25 | — | $646.0K | ||
| Q1 25 | $-73.2M | $396.0K | ||
| Q4 24 | $-249.1M | $-570.0K | ||
| Q3 24 | $-75.1M | $-532.0K | ||
| Q2 24 | $-65.8M | $107.0K | ||
| Q1 24 | $-50.3M | $-452.0K |
| Q4 25 | $-235.9M | $-827.0K | ||
| Q3 25 | $-62.1M | $-2.1M | ||
| Q2 25 | — | $-604.0K | ||
| Q1 25 | $-73.6M | $-930.0K | ||
| Q4 24 | $-251.1M | $-1.7M | ||
| Q3 24 | $-75.3M | $-2.0M | ||
| Q2 24 | $-65.8M | $-94.0K | ||
| Q1 24 | $-52.1M | $-900.0K |
| Q4 25 | -3370.0% | -11.7% | ||
| Q3 25 | — | -22.9% | ||
| Q2 25 | — | -8.2% | ||
| Q1 25 | -958.4% | -9.8% | ||
| Q4 24 | — | -22.9% | ||
| Q3 24 | — | -21.8% | ||
| Q2 24 | — | -1.2% | ||
| Q1 24 | -520.7% | -10.5% |
| Q4 25 | 5.9% | 14.2% | ||
| Q3 25 | — | 11.0% | ||
| Q2 25 | — | 16.9% | ||
| Q1 25 | 5.0% | 14.0% | ||
| Q4 24 | — | 15.4% | ||
| Q3 24 | — | 15.9% | ||
| Q2 24 | — | 2.5% | ||
| Q1 24 | 17.8% | 5.2% |
| Q4 25 | — | — | ||
| Q3 25 | — | -1.31× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 3.54× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
RLAY
Segment breakdown not available.
TPCS
| Defense | $6.7M | 94% |
| Other | $410.0K | 6% |
